Skip to main content
NOVAVAX INC logo

NOVAVAX INC — Investor Relations & Filings

Ticker · NVAX ISIN · US6700024010 LEI · 529900J4GJHPEPQ23205 US Manufacturing
Open in API
Filings indexed 1,095 across all filing types
Latest filing 2017-09-11 Major Shareholding Noti…
Country US United States of America
Listing US NVAX

About NOVAVAX INC

https://www.novavax.com/?locale=US

Novavax Inc. is a biotechnology company that develops and commercializes vaccines to prevent serious infectious diseases. The company utilizes a proprietary, protein-based vaccine technology platform, which includes its novel Matrix-M™ adjuvant, to create its vaccine candidates. Its primary commercial product is a protein-based COVID-19 vaccine, Nuvaxovid™. Novavax's research and development pipeline is focused on addressing significant health needs, including influenza and a combination COVID-19-influenza vaccine. The company's strategy emphasizes advancing its pipeline assets and establishing strategic partnerships to maximize the global health impact of its technology.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2017
Major Shareholding Notification
2017-09-11 English
FORM 4 SUBMISSION
Director's Dealing
2017-09-01 English
S-8
Regulatory Filings Classification · 100% confidence The document is a Form S-8 Registration Statement filed with the SEC by Novavax, Inc. It registers additional shares under the company's stock incentive plan. The text includes details about the registration fee, incorporation by reference of other SEC filings, indemnification provisions, and undertakings related to the registration statement. Form S-8 is a specific SEC filing used to register securities to be offered to employees under stock plans. It is not a financial report, earnings release, or management discussion. It is a regulatory filing related to securities registration and compliance with the Securities Act of 1933. Therefore, the appropriate classification is Regulatory Filings (RNS). The document length and content confirm it is not a brief announcement or a report publication announcement but a substantive regulatory filing.
2017-08-09 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The text specifically mentions Item 2.02 "Results of Operations and Financial Condition" and references a press release dated August 8, 2017, announcing the company's financial results for the quarter ended June 30, 2017. The document states that the press release is attached as Exhibit 99.1. The length of the document is 3992 characters, which is relatively short and primarily serves to announce the earnings release rather than provide detailed financial statements or analysis. According to the rules, an initial announcement of quarterly financial results with key highlights only is classified as an Earnings Release (ER). Therefore, this document is best classified as an Earnings Release (ER).
2017-08-09 English
FORM 10-Q
Interim / Quarterly Report Q2 2017
2017-08-08 English
FORM 4 SUBMISSION
Director's Dealing
2017-08-01 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.